A systematic review of multimodal prehabilitation in breast cancer Kellie TooheyMaddison HunterCatherine Paterson Review Open access 21 October 2022 Pages: 1 - 37
Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance Shelley PotterKatherine FairhurstStuart A. McIntosh Review Open access 01 November 2022 Pages: 39 - 49
Emerging strategies: PARP inhibitors in combination with immune checkpoint blockade in BRCA1 and BRCA2 mutation-associated and triple-negative breast cancer Tanya GuptaShaveta VinayakMelinda Telli Review 01 November 2022 Pages: 51 - 56
EGFR as a potent CAR T target in triple negative breast cancer brain metastases Siddharth SubhamJohn D. JeppsonDavid Akhavan Preclinical study 01 November 2022 Pages: 57 - 69
Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis Cao LuYang YangZhang peisen Preclinical study 05 November 2022 Pages: 71 - 82
Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective Alina A. GhazalehTristan M. HandschinKatrin Seidenstuecker Clinical trial Open access 26 October 2022 Pages: 83 - 92
Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial Xiao-Feng XieQiu-Yi ZhangCai-Wen Du Clinical trial Open access 30 October 2022 Pages: 93 - 101
Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer Giovanni CorsoAntonia GirardiBernardo Bonanni Clinical trial 04 November 2022 Pages: 103 - 112
Investigating the role of core needle biopsy in evaluating tumor-stroma ratio (TSR) of invasive breast cancer: a retrospective study Minh-Khang LeToru OdateTetsuo Kondo Clinical trial 06 November 2022 Pages: 113 - 121
Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis Anouk H. EijkelboomLinda de MunckSabine Siesling Epidemiology Open access 31 October 2022 Pages: 123 - 135
Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study Laura A. HuppertZak WalkerA. Jo Chien Epidemiology 02 November 2022 Pages: 137 - 148
A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia Mark PowellSophia FullerChristopher Benz Epidemiology Open access 04 November 2022 Pages: 149 - 159
Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study Anouk H. EijkelboomLinda de MunckThe COVID and Cancer Care-NL Consortium Epidemiology Open access 05 November 2022 Pages: 161 - 175
Implications of missing data on reported breast cancer mortality Jennifer K. PlichtaChristel N. RushingRachel A. Greenup Epidemiology 05 November 2022 Pages: 177 - 187
Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population Ruixian ChenYana QiJie Chen Epidemiology Open access 08 November 2022 Pages: 189 - 200
Impact of a pre-existing diagnosis of mental illness on stage of breast cancer diagnosis among older women Manami BhattacharyaHelen ParsonsDonna McAlpine Epidemiology 09 November 2022 Pages: 201 - 210
Development of a key performance indicator for breast cancer in Queensland, Australia Euan T. WalpolePhilippa H. YoulShoni Philpot Epidemiology Open access 09 November 2022 Pages: 211 - 221
Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer Joan M. NeunerNicole FergestromAaron N. Winn Epidemiology 10 November 2022 Pages: 223 - 233
Superficial and functional imaging of the tricipital lymphatic pathway: a modern reintroduction Rosie FriedmanValeria P. BustosDhruv Singhal Original Laboratory Investigation 03 November 2022 Pages: 235 - 242
Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary Fei-Lin QuJun-Jie LiZhi-Ming Shao Letter to the Editor 30 October 2022 Pages: 243 - 244